Description: Formosa Laboratories, Inc. produces and sells active pharmaceutical ingredients (APIs) worldwide. The company offers APIs in the areas of anticancer, anti-inflammatory and analgesic agents, MRI enhancing agents, cholesterol and phosphate binders, CNS agents, immunomodulators, respiratory agents, steroids, vitamin D derivatives, and antibiotics. It also provides contract development and manufacturing services; solutions for manufacturing antibody-drug conjugates; and injectable manufacturing services. The company was founded in 1995 and is based in Taoyuan City, Taiwan.
Home Page: www.formosalab.com
36 Hoping Street
Taoyuan City,
33842
Taiwan
Phone:
886 3 324 0895
Officers
| Name | Title |
|---|---|
| Dr. Chen-Yu Cheng Ph.D. | Pres & Chairman |
| Dr. C. P. Yang | Chief Exec. Officer |
| Ms. Michelle Lo | VP of Fin. |
| Mr. Jinnyuan Lin | Assistant VP of Bus. Devel. & Investment |
| Dr. Chien Hsing Lin | VP of Legal & Strategy Planning Department |
| Ms. S. J. Liou B.S. | VP of Marketing and Sales |
Exchange: TW
Country: TW
Currency: New Taiwan Dollar (NT$)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.021 |
| Price-to-Sales TTM: | 2.4914 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |